BNTX
USDBioNTech SE American Depositary Share
Цена в режиме реального времени
График цен
Ключевые показатели
Рыночные показатели
Открытие
$104.320
Максимум
$107.000
Минимум
$104.215
Объем
0.13M
Фундаментальные показатели компании
Рыночная капитализация
25.2B
Отрасль
Биотехнология
Страна
Germany
Статистические данные торговли
Средний объем
0.85M
Биржа
NMS
Валюта
USD
52-недельный диапазон
Связанные новости
HC Wainwright & Co. Maintains Buy on BioNTech, Raises Price Target to $140
HC Wainwright & Co. analyst Robert Burns maintains BioNTech with a Buy and raises the price target from $136 to $140.
BioNTech Announces Third Quarter 2025 Financial Results and Corporate Update
Continued clinical execution of oncology strategy with focus on two pan-tumor programs, including combination approaches to address the full continuum of cancer from early to late disease stagesDemonstrated encouraging
BioNTech to Host Innovation Series R&D Day on November 11, 2025
MAINZ, Germany, October 28, 2025 (GLOBE NEWSWIRE) -- BioNTech SE (NASDAQ:BNTX, "BioNTech" or "the Company")), will host an edition of the Company's Innovation Series R&D Day at 09:00 a.m. Eastern Standard Time (3:00
BioNTech to Report Third Quarter 2025 Financial Results and Corporate Update on November 3, 2025
MAINZ, Germany, October 27, 2025 (GLOBE NEWSWIRE) -- BioNTech SE (NASDAQ:BNTX, "BioNTech" or "the Company")) will announce its financial results for the third quarter 2025 on Monday, November 3, 2025. Additionally, the
JP Morgan Maintains Neutral on BioNTech, Lowers Price Target to $120
JP Morgan analyst Jessica Fye maintains BioNTech with a Neutral and lowers the price target from $121 to $120.
BioNTech Commences Public Exchange Offer for All Outstanding Shares of CureVac N.V.
Acquisition aims to strengthen the research, development, manufacturing and commercialization of mRNA-based cancer immunotherapy candidates, marking BioNTech's next milestone in the execution of its oncology
Связанные акции
PDSB
PDS Biotechnology Corporation
KNSA
Kiniksa Pharmaceuticals International plc Ordinary Shares
ABOS
Acumen Pharmaceuticals Inc.
UHS
Universal Health Services Inc.
SER
Serina Therapeutics Inc.
Оставаться в курсе
Установите ценовой сигнал, получите обновления анализа ИИ и новости рынка в режиме реального времени.